Alexza Pharmaceuticals (NASDAQ:ALXA) is an emerging specialty pharmaceutical company focused on the treatment of acute and intermittent conditions.

Amaranth was originally seeded in Singapore by Bio One Capital and focuses on developing bio-absorbable stent technologies for occlusive peripheral vascular disease.

Biosensors (SGX: B20) develops, manufactures and commercializes innovative medical devices used in interventional cardiology and critical care procedures.

Broncus Technologies develops minimally-invasive medical devices for lung diseases, including lung cancer and emphysema.

Conformis provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.

Dx Assays is a molecular diagnostics joint venture between Bio*One Capital and QIAGEN (QGEN) focused on developing and validating assay tests for infectious diseases and oncology applications.

Established in 2000, ES Cell International has been at the forefront of developing new and novel human embryonic stem cell technology.

Fluidigm develops absolute quantification systems to help advance life science and allied fields, including molecular diagnostics, personalized medicine, and wildlife conservation.

Innoheart is a preclinical Contract Research Organization (CRO) providing evaluation in the areas of Biomedical Devices, Biologics and other Medical Implants.

Merlin is a Singapore-based medical device company that is developing a novel device the treatment of cerebral or intracranial aneurysms.

Acquired by Bayer Diabetes Care in 2006, Metrika manufactures and markets a meter-based diabetes monitoring system.

OptiMedica is an ophthalmic device company based in Santa Clara, California, that designs, develops, and commercializes technologies to treat major eye diseases and disorders.

SpineVision is an integrated spinal technology company focused on the development and marketing of implants and instrumentation for spinal treatment.